2-Ethyl-5-carboxypentyl phthalate


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0003016 Respiratory system process Decreases phenotype PMID:30737192
GO:0003093 Regulation of glomerular filtration Affects phenotype PMID:32645486
GO:0006672 Ceramide metabolic process Affects phenotype PMID:35075242
GO:0035936 Testosterone secretion Decreases phenotype PMID:24945889
GO:0043396 Corticotropin-releasing hormone secretion Decreases phenotype PMID:31093596
GO:0046339 Diacylglycerol metabolic process Affects phenotype PMID:35075242
GO:0090181 Regulation of cholesterol metabolic process Affects phenotype PMID:37093692
GO:0140747 Regulation of ncrna transcription Affects phenotype PMID:37003585
GO:1902612 Regulation of anti-mullerian hormone signaling pathway Affects phenotype PMID:29206197
GO:1902894 Negative regulation of mirna transcription Increases phenotype PMID:37003585
GO:2000609 Regulation of thyroid hormone generation Affects phenotype PMID:32464474
GO:2000610 Negative regulation of thyroid hormone generation Increases phenotype PMID:29734584; PMID:34708313; PMID:38042133
GO:2000611 Positive regulation of thyroid hormone generation Affects phenotype PMID:34708313
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.